About Aurenyx Pharmatech Private Limited
Data last updated:
Aurenyx Pharmatech Private Limited is a private limited company based in Shirur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2011PTC138608. Its GSTIN is 27AAECC2908E1ZZ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sachin Bhausaheb Bhalekar and Balvant Kakaso Nawale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 841 Hudaco Colony Shirur, Pune, Maharashtra, India – 412210.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.57 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹3.92 Lakh (net margin -12.4%) and EBITDA of ₹5.57 Lakh (EBITDA margin 17.7%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cyclonepharma.com.
Company details
Contact details
Aurenyx Pharmatech Private Limited's registered office is in Shirur, Maharashtra. Its website is cyclonepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address841 Hudaco Colony Shirur, Pune, Maharashtra, India – 412210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aurenyx Pharmatech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aurenyx Pharmatech is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Aurenyx Pharmatech Private Limited, buy the company report.
Financials of Aurenyx Pharmatech Private Limited
FY 2025 filings availableAurenyx Pharmatech Private Limited reported revenue of ₹31.57 Lakh (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 29% growth in the latest year. EBITDA rose 140% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.7% | ||||
| Net Profit Margin | -12.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aurenyx Pharmatech Private Limited, buy the company report.
Board of directors of Aurenyx Pharmatech Private Limited
Aurenyx Pharmatech has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balvant Kakaso Nawale Also directs: Medcyclo Private Limited | Additional Director | 20 Aug 2020 | 6 Years 2 Months | Current |
| Sachin Bhausaheb Bhalekar | Director | 21 Feb 2011 | 15 Years 8 Months | Current |
| Shrikant Balkrishna Shrigadi | Additional Director | 12 Jan 2026 | 0 Years 9 Months | Current |
| Vaishnavi Subhash Pannase | Additional Director | 12 Jan 2026 | 0 Years 9 Months | Current |
Auditor
Aurenyx Pharmatech Private Limited is audited by JATIN RATHOR & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JATIN RATHOR & ASSOCIATES | FY 2020 | 136691W |
Shareholding
The shareholding of Aurenyx Pharmatech Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Aurenyx Pharmatech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aurenyx Pharmatech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aurenyx Pharmatech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aurenyx Pharmatech Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
Aurenyx Pharmatech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECC2908E1ZZ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aurenyx Pharmatech Private Limited, buy the company report.
Recent activity
Aurenyx Pharmatech Private Limited has 9 board changes on record since 2011: 4 appointments and 5 cessations. The latest: Shrikant Balkrishna Shrigadi was appointed as Additional Director on 12 Jan 2026.
Frequently asked questions
Aurenyx Pharmatech is an active private limited company based in Shirur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 February 2011 (15+ years old) and is registered under CIN U74900PN2011PTC138608.
Aurenyx Pharmatech has 4 current directors:
- Balvant Kakaso Nawale - Additional Director
- Sachin Bhausaheb Bhalekar - Director
- Shrikant Balkrishna Shrigadi - Additional Director
- Vaishnavi Subhash Pannase - Additional Director
The latest financial statements of Aurenyx Pharmatech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aurenyx Pharmatech is 27AAECC2908E1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aurenyx Pharmatech is U74900PN2011PTC138608. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurenyx Pharmatech was incorporated on 21 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.
Shrikant Balkrishna Shrigadi was appointed as Additional Director on 12 Jan 2026. Vaishnavi Subhash Pannase was appointed as Additional Director on 12 Jan 2026. Balvant Kakaso Nawale was appointed as Additional Director on 20 Aug 2020. Aurenyx Pharmatech has 9 board changes on record in total.
Aurenyx Pharmatech can be reached through the website cyclonepharma.com. Its registered office is in Shirur, Maharashtra, India.
The registered office of Aurenyx Pharmatech is at 841 Hudaco Colony Shirur, Pune, Maharashtra, India – 412210.
Aurenyx Pharmatech operates in the pharma industry, in the drug formulation and development segment.